Skip to main content

Table 5 Haplotypes of SNPs in patients and controls

From: Mutations in PGRN gene associated with the risk of psoriasis in Pakistan: a case control study

Haplotype

Patients (freq)

Controls (freq)

χ2

p value

OR [95% CI]

TGA

120 (0.35)

253 (0.74)

104.3

p < 0.001

0.19 [0.14–0.26]

CGA

13 (0.04)

27 (0.08)

5.204

p < 0.05

0.46 [0.23–0.91]

CAA

140 (0.41)

27 (0.08)

101.15

p < 0.001

8.085 [5.16–12.66]

CAG

69 (0.20)

25 (0.07)

23.877

p < 0.001

3.204 [1.97–5.21]

  1. Allelic combinations with a frequency lower than 3% in the subjects were excluded from analysis